149 related articles for article (PubMed ID: 32882179)
1. Valproic Acid Thermally Destabilizes and Inhibits SpyCas9 Activity.
Cheng X
Mol Ther; 2020 Dec; 28(12):2635-2641. PubMed ID: 32882179
[TBL] [Abstract][Full Text] [Related]
2. Solution structure and dynamics of anti-CRISPR AcrIIA4, the Cas9 inhibitor.
Kim I; Jeong M; Ka D; Han M; Kim NK; Bae E; Suh JY
Sci Rep; 2018 Mar; 8(1):3883. PubMed ID: 29497118
[TBL] [Abstract][Full Text] [Related]
3. Valproic Acid Significantly Improves CRISPR/Cas9-Mediated Gene Editing.
Park H; Shin J; Choi H; Cho B; Kim J
Cells; 2020 Jun; 9(6):. PubMed ID: 32532133
[TBL] [Abstract][Full Text] [Related]
4. Recent Updates of the CRISPR/Cas9 Genome Editing System: Novel Approaches to Regulate Its Spatiotemporal Control by Genetic and Physicochemical Strategies.
Allemailem KS; Almatroudi A; Rahmani AH; Alrumaihi F; Alradhi AE; Alsubaiyel AM; Algahtani M; Almousa RM; Mahzari A; Sindi AAA; Dobie G; Khan AA
Int J Nanomedicine; 2024; 19():5335-5363. PubMed ID: 38859956
[TBL] [Abstract][Full Text] [Related]
5. Catalytically Enhanced Cas9 through Directed Protein Evolution.
Hand TH; Roth MO; Smith CL; Shiel E; Klein KN; Gilbert DM; Li H
CRISPR J; 2021 Apr; 4(2):223-232. PubMed ID: 33876948
[TBL] [Abstract][Full Text] [Related]
6. Structural basis of CRISPR-SpyCas9 inhibition by an anti-CRISPR protein.
Dong D; Guo M; Wang S; Zhu Y; Wang S; Xiong Z; Yang J; Xu Z; Huang Z
Nature; 2017 Jun; 546(7658):436-439. PubMed ID: 28448066
[TBL] [Abstract][Full Text] [Related]
7. Potent CRISPR-Cas9 inhibitors from
Watters KE; Shivram H; Fellmann C; Lew RJ; McMahon B; Doudna JA
Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6531-6539. PubMed ID: 32156733
[TBL] [Abstract][Full Text] [Related]
8. Engineered CRISPR/Cas9 enzymes improve discrimination by slowing DNA cleavage to allow release of off-target DNA.
Liu MS; Gong S; Yu HH; Jung K; Johnson KA; Taylor DW
Nat Commun; 2020 Jul; 11(1):3576. PubMed ID: 32681021
[TBL] [Abstract][Full Text] [Related]
9. Development of a CRISPR/Cas9 System for Methylococcus capsulatus
Tapscott T; Guarnieri MT; Henard CA
Appl Environ Microbiol; 2019 Jun; 85(11):. PubMed ID: 30926729
[TBL] [Abstract][Full Text] [Related]
10.
Yourik P; Fuchs RT; Mabuchi M; Curcuru JL; Robb GB
RNA; 2019 Jan; 25(1):35-44. PubMed ID: 30348755
[TBL] [Abstract][Full Text] [Related]
11. CRISPR/Cas gene therapy.
Zhang B
J Cell Physiol; 2021 Apr; 236(4):2459-2481. PubMed ID: 32959897
[TBL] [Abstract][Full Text] [Related]
12. Anti-CRISPR AcrIIA5 Potently Inhibits All Cas9 Homologs Used for Genome Editing.
Garcia B; Lee J; Edraki A; Hidalgo-Reyes Y; Erwood S; Mir A; Trost CN; Seroussi U; Stanley SY; Cohn RD; Claycomb JM; Sontheimer EJ; Maxwell KL; Davidson AR
Cell Rep; 2019 Nov; 29(7):1739-1746.e5. PubMed ID: 31722192
[TBL] [Abstract][Full Text] [Related]
13. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
14. Improving CRISPR-Cas9 Genome Editing Efficiency by Fusion with Chromatin-Modulating Peptides.
Ding X; Seebeck T; Feng Y; Jiang Y; Davis GD; Chen F
CRISPR J; 2019 Feb; 2():51-63. PubMed ID: 31021236
[TBL] [Abstract][Full Text] [Related]
15. Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)/CRISPR-Associated Endonuclease Cas9-Mediated Homology-Independent Integration for Generating Quality Control Materials for Clinical Molecular Genetic Testing.
Lin G; Zhang K; Peng R; Han Y; Xie J; Li J
J Mol Diagn; 2018 May; 20(3):373-380. PubMed ID: 29680088
[TBL] [Abstract][Full Text] [Related]
16. SMOOT libraries and phage-induced directed evolution of Cas9 to engineer reduced off-target activity.
Cerchione D; Loveluck K; Tillotson EL; Harbinski F; DaSilva J; Kelley CP; Keston-Smith E; Fernandez CA; Myer VE; Jayaram H; Steinberg BE
PLoS One; 2020; 15(4):e0231716. PubMed ID: 32298334
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9-mediated genome editing of splicing mutation causing congenital hearing loss.
Ryu N; Kim MA; Choi DG; Kim YR; Sonn JK; Lee KY; Kim UK
Gene; 2019 Jun; 703():83-90. PubMed ID: 30898719
[TBL] [Abstract][Full Text] [Related]
18. Editing of the Bacillus subtilis Genome by the CRISPR-Cas9 System.
Altenbuchner J
Appl Environ Microbiol; 2016 Sep; 82(17):5421-7. PubMed ID: 27342565
[TBL] [Abstract][Full Text] [Related]
19. The final cut: Cas9 editing.
Taylor DW
Nat Struct Mol Biol; 2019 Aug; 26(8):669-670. PubMed ID: 31285603
[No Abstract] [Full Text] [Related]
20. A glance at genome editing with CRISPR-Cas9 technology.
Barman A; Deb B; Chakraborty S
Curr Genet; 2020 Jun; 66(3):447-462. PubMed ID: 31691023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
